
AOD-9604
Also called hGH fragment 176-191
- Evidence
- Limited research
- Class
- GH fragment (lipolytic)
AOD-9604 belongs to the GH fragment (lipolytic) class. This library groups it under digestive & weight. Its source category is Not FDA-approved.
At a glance
| Compound class | GH fragment (lipolytic) |
|---|---|
| Body system | Digestive & weight |
| Use or research focus | Fat loss |
| Regulatory status | Not FDA-approved (failed obesity trials; prior GRAS bid) |
| Source evidence rating | Limited research |
How does AOD-9604 work?
Stimulates lipolysis without GH/IGF effects.
The source catalog maps this mechanism to Adipose / Fat. A biological mechanism describes how a compound interacts with the body; it does not by itself prove a clinical benefit.
What does the evidence tell us?
The source catalog rates the evidence as limited. Laboratory and animal findings cannot establish benefits or safety in people. Small or early studies may raise useful research questions without supporting routine clinical use.
Use the Citations tab to examine the underlying sources. Look for human studies, a relevant comparison group, meaningful outcomes, and adequate follow-up. An ingredient, approved drug, and compounded preparation may have different evidence.
Safety and considerations
For an unapproved use or compound, safety and effectiveness may be uncertain. Products sold for research are not a substitute for prescribed care. Do not infer a human dose, injection protocol, or treatment recommendation from preclinical research.
This library is educational and does not provide dosing or treatment instructions. A listing here does not indicate that Peppy offers the compound.
Common questions
What is AOD-9604?
AOD-9604 belongs to the GH fragment (lipolytic) class. This library groups it under digestive & weight. Its source category is Not FDA-approved. Its recorded use or research focus is: Fat loss.
Is AOD-9604 FDA-approved?
The catalog records: Not FDA-approved (failed obesity trials; prior GRAS bid). Check the current product-specific regulatory information in the source links; a source category does not establish approval for every use or formulation.
How strong is the research?
The source catalog rates the evidence as limited. Laboratory and animal findings cannot establish benefits or safety in people. Small or early studies may raise useful research questions without supporting routine clinical use.
Where can I read the research?
The Citations tab contains 11 reference links from the source dataset. The original research guide provides additional context. These links are a starting point for reading the evidence.
More for digestive & weight
Factual catalog fields and citation links are adapted from Superpower’s AOD-9604 guide and the public dataset linked in the reference post. Peppy’s explanations are educational; this page does not represent an independent clinical review of every linked study.
Sources & further reading
References associated with AOD-9604 in the source dataset. Open a source to review its study design, population, limitations, and date.
- 01heredoi.org
- 02heredoi.org
- 03did not produce significant weight losspubmed.ncbi.nlm.nih.gov
- 04amino acids 177 to 191pubmed.ncbi.nlm.nih.gov
- 05191 amino acids of full-length hGHdailymed.nlm.nih.gov
- 06AOD-9604 does not register on the WADApubmed.ncbi.nlm.nih.gov
- 07substances that may present significant safety risksfda.gov
- 08WADA Prohibited Listwada-ama.org
- 09Category 1fda.gov
- 10FDA approvalaccessdata.fda.gov
- 112007 NEJM studypubmed.ncbi.nlm.nih.gov





